Investors can explore detailed stock insights including earnings analysis, valuation metrics, and market momentum indicators across listed companies.
As of 2026-04-06, Theriva Biologics Inc. (TOVX) is trading at $0.25 per share, posting an intraday gain of 8.09% at the time of writing. No recent earnings data is available for the firm as of this analysis, so price action is currently being driven by technical levels, broader sector sentiment, and investor expectations for upcoming corporate catalysts. This analysis outlines key near-term technical markers, market context for small-cap biotech trading, and potential short-term price scenarios
Will Theriva Biologics (TOVX) Stock Grow in 2026 | Price at $0.25, Up 8.09% - Weak Sell Signals
TOVX - Stock Analysis
3602 Comments
1802 Likes
1
Kana
Legendary User
2 hours ago
{协议答案}
👍 93
Reply
2
Julianne
Trusted Reader
5 hours ago
{协议答案}
👍 228
Reply
3
Shehzeen
Daily Reader
1 day ago
{协议答案}
👍 98
Reply
4
Elyjah
Consistent User
1 day ago
{协议答案}
👍 282
Reply
5
Covington
Legendary User
2 days ago
{协议答案}
👍 292
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.